Triethylenetetramine (TETA)
Toxicology and Industrial Health · 2023-04 · 39 (4) · 183-187
DOI: 10.1177/07482337231161152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicology and Industrial Health, online erschienen am 20.03.2023. Verfasst von Workplace Environmental Exposure Level (WEEL) Committee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cincinnati, OH, USA. Hauptthemen laut MEDLINE: Trientine, Hepatolenticular Degeneration. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
The WEEL for triethylenetetramine (TETA; CAS No. 112-24-3) was originally established in 1991 and updated in 1998 and 2009. Recent literature searches to identify new toxicity information were performed in 2016 and January 2021. No new studies or data relevant to the WEEL were identified. TETA is used in manufacturing; the hydrochloride salt of TETA is used as a copper-chelating drug in the treatment of Wilson’s disease. TETA is severely irritating to the skin and eyes and produces skin sensitization; however, it is of low to moderate acute toxicity via the oral and dermal routes of exposure. In subchronic studies, signs of toxicity included multi-organ effects (lung, liver, and spleen) in mice, but not rats. TETA was genotoxic/mutagenic in short-term in vitro assays but not in in vivo assays. No data on reproductive toxicity were available. Embryo/fetal toxicity occurred at maternally toxic doses and was associated with copper deficiency. In humans, the use of TETA·2HCl for treatment of Wilson’s disease during pregnancy resulted in no miscarriages or fetal abnormalities. No evidence of carcinogenicity was noted in a lifetime dermal study in mice. Based on a subchronic drinking water study in mice, 600 ppm (95 mg/kg-day) was determined to be the no-observed-adverse-effect level (NOAEL) and the point of departure (POD). This NOAEL was converted to an equivalent inhalation concentration by adjusting for respiratory rate, interindividual variability, and uncertainty. The resulting 8-h time-weighted average WEEL value of 1 ppm is expected to provide a significant margin of safety against any potential adverse health effects in workers exposed to airborne TETA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cincinnati, OH, USA.
Zitieren
APA
Workplace Environmental Exposure Level (WEEL) Committee, Occupational Alliance for Risk Science (OARS), & Toxicology Excellence for Risk Assessment (TERA) (2023). Triethylenetetramine (TETA). Toxicology and Industrial Health, 39(4), 183-187. https://doi.org/10.1177/07482337231161152
Vancouver
Workplace Environmental Exposure Level (WEEL) Committee, Occupational Alliance for Risk Science (OARS), Toxicology Excellence for Risk Assessment (TERA). Triethylenetetramine (TETA). Toxicology and Industrial Health. 2023;39(4):183-187. doi:10.1177/07482337231161152
BibTeX
@article{WorkplaceEnvironmentalExposureLevelWEELCommittee2023,
author = {Workplace Environmental Exposure Level (WEEL) Committee, Workplace Environmental Exposure Level (WEEL) Committee and Occupational Alliance for Risk Science (OARS), Occupational Alliance for Risk Science (OARS) and Toxicology Excellence for Risk Assessment (TERA), Toxicology Excellence for Risk Assessment (TERA)},
title = {Triethylenetetramine (TETA)},
journal = {Toxicology and Industrial Health},
year = {2023},
volume = {39},
number = {4},
pages = {183--187},
doi = {10.1177/07482337231161152}
}
EUVIMED